Vatsal Ladia, MD, Hemang B. Panchal, MD, MPH, Terrence J

Slides:

Advertisements

Similar presentations

I may not be Southern by birth, but I am proud to be an American: The role of international medical graduates in vascular surgery and the Southern Association.

Advertisements

Todd W. Rice, MD, Gordon R. Bernard, MD

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis Stavros Stavrakis, MD The American Journal.

Type 4 Hiatal Hernia The American Journal of the Medical Sciences

Infectious Diseases and the Criminal Justice System

Efficacy of Rifaximin, a Nonabsorbed Oral Antibiotic, in the Treatment of Small Intestinal Bacterial Overgrowth Marek Majewski, MD The American Journal.

Efficacy of Two Different Helicobacter pylori Eradication Regimens in Patients With Type 2 Diabetes and the Effect of Helicobacter pylori Eradication.

Role of Microalbuminuria in Predicting Cardiovascular Mortality in Individuals With Subclinical Hypothyroidism Tushar A. Tuliani, MD, Maithili Shenoy,

Hypertension-Lipid Connection: Introduction

Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.

Of mice and men and surgical transcatheter aortic valve insertion

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Comparative Effectiveness Research and Medical Informatics

Aruna D. Pradhan, MD, Nader Rifai, PhD, Julie E. Buring, ScD, Paul M

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh Kidney International

Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD

Diagnosis and Management of Chronic Kidney Disease

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

ESRD Care Within the US Department of Veterans Affairs: A Forward-Looking Program With an Illuminating Past Suzanne Watnick, MD, Susan T. Crowley, MD

End-stage renal disease in developing countries

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

A comprehensive review of the PARTNER trial

Volume 58, Issue 1, Pages (July 2000)

Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Overview of Current Learning Theories for Medical Educators

Urinary Ascites and Renal Failure from Unrecognized Bladder Rupture

Epidemiology of Myelodysplastic Syndromes

Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh Kidney International

Management of Patients With Aortic Valve Stenosis

Bigger valve size is not always better

Allison L. Ruff, MD, Kathryn Teng, MD, Bo Hu, PhD, Michael B

Medical professionalism and the generation gap

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Recognition for Conservative Care in Kidney Failure

Gout in African Americans

Louis L. Nguyen, MD, MBA, MPH Journal of Vascular Surgery

Francesco Paolo Schena Kidney International

Salt and Hypertension American Journal of Kidney Diseases

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

The epidemiology of chronic kidney disease

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Use of Diuretics in Heart Failure: A Precarious Balance

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Transcatheter aortic valve replacement in intermediate-risk patients

Michele Gallo, MD, Gino Gerosa, MD

Volume 58, Issue 1, Pages (July 2000)

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Replicating the success of mitral valve repair in the aortic valve

Quiz Page August 2007 American Journal of Kidney Diseases

Lynda Anne Szczech, Ira L. Lazar Kidney International

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Denise M. Dupras, MD, PhD, Randall S. Edson, MD, Andrew J

Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend G. Michael Deeb, MD, John Carroll, MD The Journal.

This Month in AJKD American Journal of Kidney Diseases

Jordi Goldstein-Fuchs, DSc, RD, RN, Denis Fouque, MD, PhD

H.J. Chin, H. Ro, H.J. Lee, K.Y. Na, D.-W. Chae Kidney International

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Commentary: When a choice is not an echo

Direct Observation of Residents: A Model for an Assessment System

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Maristela Böhlke, PhD American Journal of Kidney Diseases

Quiz page December 2003 American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

Presentation transcript:

Incidence of Renal Failure Requiring Hemodialysis Following Transcatheter Aortic Valve Replacement Vatsal Ladia, MD, Hemang B. Panchal, MD, MPH, Terrence J. O׳Neil, MD, Puja Sitwala, MD, Samit Bhatheja, MD, MPH, Rakeshkumar Patel, MD, Vijay Ramu, MD, Debabrata Mukherjee, MD, Ehtisham Mahmud, MD, Timir K. Paul, MD, PhD The American Journal of the Medical Sciences Volume 352, Issue 3, Pages 306-313 (September 2016) DOI: 10.1016/j.amjms.2016.05.018 Copyright © 2016 Southern Society for Clinical Investigation Terms and Conditions

FIGURE 1 Study selection process. The American Journal of the Medical Sciences 2016 352, 306-313DOI: (10.1016/j.amjms.2016.05.018) Copyright © 2016 Southern Society for Clinical Investigation Terms and Conditions

FIGURE 2 Meta-analysis comparison of incidence of renal failure requiring hemodialysis between TF-TAVR and TA-TAVR. The American Journal of the Medical Sciences 2016 352, 306-313DOI: (10.1016/j.amjms.2016.05.018) Copyright © 2016 Southern Society for Clinical Investigation Terms and Conditions

FIGURE 3 Meta-analysis comparison of the amount of contrast (mL) used between TF-TAVR and TA-TAVR. The American Journal of the Medical Sciences 2016 352, 306-313DOI: (10.1016/j.amjms.2016.05.018) Copyright © 2016 Southern Society for Clinical Investigation Terms and Conditions

FIGURE 4 Meta-analysis comparison of logistic EuroSCORE for hemodialysis and contrast use between TF-TAVR and TA-TAVR. The American Journal of the Medical Sciences 2016 352, 306-313DOI: (10.1016/j.amjms.2016.05.018) Copyright © 2016 Southern Society for Clinical Investigation Terms and Conditions

FIGURE 5 Baseline prevalence of diabetes mellitus between TF-TAVR and TA-TAVR. The American Journal of the Medical Sciences 2016 352, 306-313DOI: (10.1016/j.amjms.2016.05.018) Copyright © 2016 Southern Society for Clinical Investigation Terms and Conditions

FIGURE 6 Baseline prevalence of hypertension between TF-TAVR and TA-TAVR. The American Journal of the Medical Sciences 2016 352, 306-313DOI: (10.1016/j.amjms.2016.05.018) Copyright © 2016 Southern Society for Clinical Investigation Terms and Conditions

FIGURE 7 Baseline prevalence of peripheral vascular disease between TF-TAVR and TA-TAVR. The American Journal of the Medical Sciences 2016 352, 306-313DOI: (10.1016/j.amjms.2016.05.018) Copyright © 2016 Southern Society for Clinical Investigation Terms and Conditions

FIGURE 8 Baseline prevalence of chronic kidney disease between TF-TAVR and TA-TAVR. The American Journal of the Medical Sciences 2016 352, 306-313DOI: (10.1016/j.amjms.2016.05.018) Copyright © 2016 Southern Society for Clinical Investigation Terms and Conditions